Denali Therapeutics Inc (DNLI)

Other Income/Expenses (Net)

$31.35M

TTM · Period ending: · USD

DNLI logo

DNLI Other Income/Expenses (Net)

Latest reported$31.35M
DNLI Other Income/Expenses (Net) (-$109.00K → $31.35M)
High-resolution chart · PNG

DNLI other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
42,904,000
64,636,000
51,505,000
14,774,000
4,595,000
9,241,000
15,219,000
10,132,000
1,955,000
781,000
-109,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.